Role of Vitamin C at 6 Months on Incidence of Complex Regional Pain Syndrome Type I in Upper Limb Surgery
NCT ID: NCT02390505
Last Updated: 2023-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
1000 participants
INTERVENTIONAL
2016-07-18
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prophylactic Administration of Vitamin C in Wrist Fractures
NCT00296868
Vitamin C on Acute and Chronic Post Mastectomy Pain
NCT05770596
Preoperative Melatonin or Vitamin C Administration on Postoperative Analgesia
NCT02639741
The Effectiveness of Vitamin C in Postoperative Pain Management of Single-level Posterior Lumbar Interbody Fusion (PLIF)
NCT02127060
Caffeine and Neurologic Recovery Following Surgery and General Anesthesia
NCT03577730
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The management of CRPS type 1 is long and expensive. A preventive care seems beneficial. Some studies already performed suggest a similar role in scheduled surgery of the upper limb, major provider of CRPS type 1.The aim of the study is to demonstrate a significant reduction of CRPS 1 when taking vitamin C during the perioperative period in upper limb surgery. It is a prospective, randomized, double-blind, with placebo use, in two parallel group, multicenter and national. Patients are followed by their surgeon, under the terms of monitoring their disease. Two visits are required: one at 6 months and at 12 months. The patients will be reviewed at least in the two consultations looking for CRPS type 1 according to the criteria of the International Association for the Study of Pain (IASP)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin C
Patients receive vitamin C at a daily dose of 500 mg orally: 7 days before and during 6 weeks after surgery
Vitamin C
Placebo
Patients receive placebo at a daily dose of 500 mg orally: 7 days before and during 6 weeks after surgery
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin C
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients undergoing major surgery of the upper limb
* patients able to give their consent to follow the protocol of treatment and monitoring.
Exclusion Criteria
* patients under guardianship,
* pregnant or lactating women,
* patients with hemochromatosis,
* allergy or known hypersensitivity to one of the molecules of treatment,
* patients suffering or having already suffered from complex regional pain syndrome type 1 or type 2,
* patients unable due to personal or professional mobility, to conduct post-operative follow up,
* patients undergoing surgery with nerve suture with nerve graft, emergency surgery,
* patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency,
* patients with chronic kidney disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emmanuel DAVID, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Amiens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens
Amiens, , France
CHU Rouen
Rouen, , France
CH Saint-Quentin
Saint-Quentin, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-000145-24
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
PI2015_843_0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.